CN1094345C - 高剂量脂质体气溶胶制剂 - Google Patents

高剂量脂质体气溶胶制剂 Download PDF

Info

Publication number
CN1094345C
CN1094345C CN97196141A CN97196141A CN1094345C CN 1094345 C CN1094345 C CN 1094345C CN 97196141 A CN97196141 A CN 97196141A CN 97196141 A CN97196141 A CN 97196141A CN 1094345 C CN1094345 C CN 1094345C
Authority
CN
China
Prior art keywords
liposome
budesonide
aerosol composition
dlpc
cyclosporin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN97196141A
Other languages
English (en)
Chinese (zh)
Other versions
CN1224347A (zh
Inventor
J·C·沃尔德莱普
V·奈特
M·B·布莱克
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RESEARCH DEVELOPMENT FOUDATION
Original Assignee
RESEARCH DEVELOPMENT FOUDATION
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/731,605 external-priority patent/US5958378A/en
Application filed by RESEARCH DEVELOPMENT FOUDATION filed Critical RESEARCH DEVELOPMENT FOUDATION
Publication of CN1224347A publication Critical patent/CN1224347A/zh
Application granted granted Critical
Publication of CN1094345C publication Critical patent/CN1094345C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN97196141A 1996-07-03 1997-07-02 高剂量脂质体气溶胶制剂 Expired - Fee Related CN1094345C (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US67565496A 1996-07-03 1996-07-03
US08/675,654 1996-07-03
US08/731,605 1996-10-16
US08/731,605 US5958378A (en) 1996-07-03 1996-10-16 High dose liposomal aerosol formulations containing cyclosporin A or budesonide

Publications (2)

Publication Number Publication Date
CN1224347A CN1224347A (zh) 1999-07-28
CN1094345C true CN1094345C (zh) 2002-11-20

Family

ID=27101390

Family Applications (1)

Application Number Title Priority Date Filing Date
CN97196141A Expired - Fee Related CN1094345C (zh) 1996-07-03 1997-07-02 高剂量脂质体气溶胶制剂

Country Status (10)

Country Link
EP (1) EP0959874B1 (enExample)
JP (1) JP2001524930A (enExample)
CN (1) CN1094345C (enExample)
AT (2) ATE268163T1 (enExample)
AU (1) AU732124B2 (enExample)
CA (1) CA2259185C (enExample)
DE (2) DE69729391T2 (enExample)
NZ (1) NZ333497A (enExample)
TW (1) TW497974B (enExample)
WO (1) WO1998000111A1 (enExample)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6417172B1 (en) * 1995-06-05 2002-07-09 Eisai Co., Ltd. Prevention and treatment of pulmonary bacterial infection or symptomatic pulmonary exposure to endotoxin by inhalation of antiendotoxin drugs
US5863910A (en) * 1996-01-12 1999-01-26 Bolonick; Joel Treatment of chronic inflammatory disorders of the gastrointestinal tract
US7348025B2 (en) 1997-09-23 2008-03-25 Research Development Foundation Small particle liposome aerosols for delivery of anticancer drugs
US6090407A (en) * 1997-09-23 2000-07-18 Research Development Foundation Small particle liposome aerosols for delivery of anti-cancer drugs
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6433040B1 (en) 1997-09-29 2002-08-13 Inhale Therapeutic Systems, Inc. Stabilized bioactive preparations and methods of use
US6946117B1 (en) 1997-09-29 2005-09-20 Nektar Therapeutics Stabilized preparations for use in nebulizers
US20020006901A1 (en) * 1999-02-05 2002-01-17 Aldo T. Iacono Use of aerosolized cyclosporine for prevention and treatment of pulmonary disease
WO2000074653A1 (en) * 1999-06-04 2000-12-14 Skyepharma, Inc. Oil-core compositions for the sustained release of hydrophobic drugs
KR100799089B1 (ko) * 1999-12-04 2008-01-29 리서치 디벨럽먼트 파운데이션 에어로졸화된 약물의 침착 증진 조성물
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
TWI290473B (en) 2000-05-10 2007-12-01 Alliance Pharma Phospholipid-based powders for drug delivery
ATE508735T1 (de) 2001-12-19 2011-05-15 Novartis Ag Pulmonale verabreichung von aminoglykosiden
EP1506032A1 (en) * 2002-05-20 2005-02-16 Research Development Foundation Aerosol drug inhibition of lung metastases
US20050255154A1 (en) 2004-05-11 2005-11-17 Lena Pereswetoff-Morath Method and composition for treating rhinitis
KR20080016621A (ko) 2005-06-09 2008-02-21 바이올리폭스 에이비 염증성 질병 치료용 조성물 및 방법
DE102006051512A1 (de) * 2005-12-06 2007-06-14 Pari GmbH Spezialisten für effektive Inhalation Pharmazeutische Medikamentenzusammensetzungen mit Cyclosporin
CN101502484B (zh) * 2006-12-26 2011-04-20 济南康泉医药科技有限公司 同载糖皮质激素和化疗药物的抗癌缓释剂
CA2705159A1 (en) * 2007-11-09 2009-05-14 Map Pharmaceuticals, Inc. Methods for administering corticosteroid formulations
PL2544663T3 (pl) 2010-03-12 2018-09-28 Berg Llc Dożylne formulacje koenzymu Q10 (CoQ10) i sposoby ich zastosowania
BR112013003658B1 (pt) 2010-07-28 2022-02-22 Life Technologies Corporation Composição farmacêutica compreendendo ácido graxo, carboidrato e lipídio de isoprenoide modificados com azida, uso de tais componentes e método para inibir infectividade de um vírus
US20120028335A1 (en) 2010-07-28 2012-02-02 Life Technologies Corporation Anti-viral azide-containing compounds
BR112013002641A2 (pt) * 2010-08-05 2016-06-07 Piramal Entpr Ltd formulação de micropartículas para administração de medicamentos pulmonares de molécula anti-infeccionais para tratamento de doenças infecciosas
CN102008713B (zh) * 2010-12-02 2012-10-24 深圳海王药业有限公司 环孢素a前体脂质体、药物组合物及其制备方法
EP2720680B1 (en) * 2011-06-17 2020-02-12 Berg LLC Inhalable pharmaceutical compositions
GB201114332D0 (en) 2011-08-19 2011-10-05 Nufarm Uk Ltd Novel inhibitor compositions and methods of use
AU2013212068B2 (en) 2012-01-26 2018-02-15 Life Technologies Corporation Methods for increasing the infectivity of viruses
JP7401471B2 (ja) * 2018-06-27 2023-12-19 ブレス テラポイティクス ゲーエムベーハー 凍結乾燥形態の医薬組成物
CN112368009A (zh) * 2018-06-27 2021-02-12 呼吸治疗公司 包含大环免疫抑制剂的可吸入的组合物
EA202092892A1 (ru) 2018-12-04 2021-05-27 Брес Терапьютикс Гмбх Ингаляционные композиции, содержащие макроциклические иммуносупрессанты

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5049388A (en) * 1986-11-06 1991-09-17 Research Development Foundation Small particle aerosol liposome and liposome-drug combinations for medical use

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8403905D0 (sv) * 1984-07-30 1984-07-30 Draco Ab Liposomes and steroid esters
SE8603812D0 (sv) * 1986-09-12 1986-09-12 Draco Ab Administration of liposomes to mammals
IE63869B1 (en) * 1986-11-06 1995-06-14 Res Dev Foundation Aerosols containing liposomes and method for their preparation
US4906476A (en) * 1988-12-14 1990-03-06 Liposome Technology, Inc. Novel liposome composition for sustained release of steroidal drugs in lungs
MX9201782A (es) * 1991-04-19 1992-10-01 Sandoz Ag Particulas de sustancias biologicamente activas, sustancialmente insolubles en agua, proceso para su produccion y composicion farmaceutica que las contiene.
DE4203306A1 (de) * 1992-02-06 1993-08-12 Ig Spruehtechnik Gmbh Asthma oder pulmonal-aerosolzubereitungen mit lecithin
AR002009A1 (es) * 1994-12-22 1998-01-07 Astra Ab Composicion farmaceutica, procedimiento para la manufactura de un polvo de proliposoma como el utilizado en dicha composicion, procedimiento para lamanufactura de dicha composicion, uso de dicha composicion farmaceutica en la manufactura de un medicamento y dispositivo inhalador de polvo seco.

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5049388A (en) * 1986-11-06 1991-09-17 Research Development Foundation Small particle aerosol liposome and liposome-drug combinations for medical use

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CA119:256383 1993.1.1 WALDREP.CYCLOSPORIN A LIPOSOME AEROSOL:PARTICLE SIZE AND CALCULATED RESPIRATORY DEPOSITION *

Also Published As

Publication number Publication date
AU3650897A (en) 1998-01-21
DE69736083T2 (de) 2006-12-28
ATE268163T1 (de) 2004-06-15
TW497974B (en) 2002-08-11
DE69729391D1 (de) 2004-07-08
WO1998000111A1 (en) 1998-01-08
AU732124B2 (en) 2001-04-12
DE69736083D1 (de) 2006-07-20
NZ333497A (en) 2000-06-23
ATE328583T1 (de) 2006-06-15
JP2001524930A (ja) 2001-12-04
EP0959874A1 (en) 1999-12-01
CA2259185A1 (en) 1998-01-08
DE69729391T2 (de) 2005-06-02
CA2259185C (en) 2009-12-15
EP0959874B1 (en) 2004-06-02
EP0959874A4 (enExample) 1999-12-22
CN1224347A (zh) 1999-07-28

Similar Documents

Publication Publication Date Title
CN1094345C (zh) 高剂量脂质体气溶胶制剂
US5958378A (en) High dose liposomal aerosol formulations containing cyclosporin A or budesonide
US5049389A (en) Novel liposome composition for the treatment of interstitial lung diseases
KR100277622B1 (ko) 흡입용 초미립자 분말 및 그의 제조방법
US5192528A (en) Corticosteroid inhalation treatment method
US5043165A (en) Novel liposome composition for sustained release of steroidal drugs
US20070065369A1 (en) Novel methods and composition for delivering macromolecules to or via the respiratory tract
TW200916126A (en) Organic compounds
CN100513417C (zh) 用于雾化的环索奈德水悬液
CN108348459A (zh) 靶向递送喷雾干燥制剂到肺
US20240226116A1 (en) Glucocorticoid Particles and Their Use
CN1681520A (zh) 脱氢表雄酮的喷雾剂和采用其组合物治疗哮喘或慢性阻塞性肺部疾病的方法
WO1990006775A1 (en) A novel nonphospholipid liposome composition for sustained release of drugs
CN115768404B (zh) 含乌美溴铵和三苯乙酸维兰特罗的药物制剂
US20020076383A1 (en) Composition and method for treatment of otitis external
EP2983646A1 (en) A pharmaceutical composition containing budesonide and formoterol.
US6645467B2 (en) Composition and method for decreasing upper respiratory airway resistance
RU2174390C2 (ru) Высокодозированные липосомные аэрозольные фармацевтические композиции
DK2704724T3 (en) Improved suspension formulation of beclomethasone dipropionate for administration by inhalation
US7141236B2 (en) Methods and compositions for delivering macromolecules to or via the respiratory tract
EP1390012A1 (en) Novel methods and compositions for delivering macromolecules to or via the respiratory tract
KR100497564B1 (ko) 고용량의리포좀에어로졸제제
Khale et al. Liposomal Nebulising Solutions of Salbutamol Sulphate-A Characterisation Study.
CN115835885A (zh) 包含奥达特罗和布地奈德的药物组合物的制备

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20021120

Termination date: 20120702